Trials / Unknown
UnknownNCT03748407
Determination of Baseline Thyroid Status Values in French Adult Population
Determination of Baseline Thyroid Status Values
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to establish reference values in the general population from a Beckman Coulter DxI chemiluminescence assay. Indeed, the lack of harmonization of the methods of the dosage remains a major difficulty to optimize the management of patients with thyroid disease. This supplier has recently optimized its dosing kit according to the 3rd international standard of the WHO (IRB 81/565) for the TSH (Thyroid Stimulating Hormon). It is necessary to carry out a study of the distribution of the values of this TSH within our metropolitan population. The current data proposed by the supplier come from a study of a North American population. investigators propose to define usual values for thyroid status markers (TSH, FT4 \[free thyroxine\], FT3 \[free triiodothyroxine\]) from healthy EFS (French Blood Establishment) donors who meet the standard exclusion criteria for this type of study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dosages of Thyroid parameters | Dosages of the following parameters: TSH, FT4 FT3, TGAb (Tyroglobulin antibody) , TPO Ab (ThyroPeroxydase Antibody) |
Timeline
- Start date
- 2018-11-30
- Primary completion
- 2018-12-01
- Completion
- 2019-01-31
- First posted
- 2018-11-20
- Last updated
- 2018-11-20
Source: ClinicalTrials.gov record NCT03748407. Inclusion in this directory is not an endorsement.